Sort
11,323 grants matching “glioblastoma”
Project 3: Predicting therapeutic sensitivity in cancer
$356,263Anna Lasorella · Columbia University Health Sciences · U54 · FY2019 · CA
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2002 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2005 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2004 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2003 · NS
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$356,170Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2018 · CA
Autophagy inhibition as a therapeutic strategy for glioblastoma mutliforme
$356,164Ravi K Amaravadi · University Of Pennsylvania · R21 · FY2009 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$356,129Hideho Okada · University Of California, San Francisco · R01 · FY2019 · CA
Glioblastoma - Molecular Analysis for Clinical Trials
$355,932University Of California Los Angeles · R01 · FY2005 · NS
Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors
$355,904Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2010 · CA
Pathology - Core A
$355,881Keith L Ligon · Brigham And Women'S Hospital · P50 · FY2019 · CA
Molecular Imaging of Cardiac Stem Cell Therapy
$355,874Joseph C Wu · Stanford University · R01 · FY2012 · EB
Mechanisms and Function of Autophagy in Cancer
$355,854Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Evading innate immunity during human cytomegalovirus latency
$355,828Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2021 · AI
Evading innate immunity during human cytomegalovirus latency
$355,828Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2022 · AI
Evading innate immunity during human cytomegalovirus latency
$355,828Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2019 · AI
Evading innate immunity during human cytomegalovirus latency
$355,828Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2020 · AI
Evading innate immunity during human cytomegalovirus latency
$355,828Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2018 · AI
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
$355,774Lauren Fishbein · University Of Colorado Denver · R01 · FY2022 · CA
Project 2 - Clinical translation
$355,767Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
Pathology Core
$355,741Keith L Ligon · Massachusetts General Hospital · P50 · FY2017 · CA
Differential response of glioblastomas to microtubule targeting agents
$355,706Nephi Stella · University Of Washington · R01 · FY2021 · CA
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
$355,705Daniel J Brat · Northwestern University At Chicago · R01 · FY2022 · CA
Overcoming therapy resistance in GBM
$355,676Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2009 · CA
Effectively Targeting Notch in Hypoxic Brain Tumor Cells
$355,639Charles George Eberhart · Johns Hopkins University · R01 · FY2014 · NS